Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04841525 · ClinicalTrials.gov registry record
Autism Biomarker Consortium for Clinical Trials (ABC-CT): Follow-up Study
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 265
- Enrollment target
NCT04841525 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 265 participants.
The verdict
NCT04841525 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 265 participants
- Enrollment target
Study Summary
This is a multicenter longitudinal follow-up study to the main study of an a registered already (NCT# ). The Follow-up Study (T4) will assess the Main Study cohort for an additional longitudinal time point approximately 2-5 years after the initial study. Children participating in the Follow-up Study will be approximately 8-16 years old. The aims of the main study is to identify, develop and validate a set of measures that can be used as stratification biomarkers and/or sensitive and reliable objective measures of social impairment in autism spectrum disorders (ASD) that could serve as markers of long term clinical outcome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2021-04-09 |
| Est. Completion | 2022-08-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04841525
The ClinicalTrials.gov registry entry for NCT04841525 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04841525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04841525 about?
NCT04841525 is a clinical study titled "Autism Biomarker Consortium for Clinical Trials (ABC-CT): Follow-up Study". This is a multicenter longitudinal follow-up study to the main study of an a registered already (NCT# ). The Follow-up Study (T4) will assess the Main Study cohort for an additional longitudinal time point approximately 2-5 years after the initial study. Children participating in the Follow-up Study...
What is the current status of trial NCT04841525?
This trial is currently completed. The enrollment target is 265 participants. The study started on 2021-04-09. Estimated completion is 2022-08-11.
Who is sponsoring clinical trial NCT04841525?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.